DD210047A5 - Verfahren zur herstellung von trans-dl-5-substituierten 7-gegebenenfalls-substituierten-4,4a,5,6,7,8,8a,9-octahydro-1h(und 2h)pyrazolo(3,4-g)chinolinen - Google Patents
Verfahren zur herstellung von trans-dl-5-substituierten 7-gegebenenfalls-substituierten-4,4a,5,6,7,8,8a,9-octahydro-1h(und 2h)pyrazolo(3,4-g)chinolinen Download PDFInfo
- Publication number
- DD210047A5 DD210047A5 DD83253428A DD25342883A DD210047A5 DD 210047 A5 DD210047 A5 DD 210047A5 DD 83253428 A DD83253428 A DD 83253428A DD 25342883 A DD25342883 A DD 25342883A DD 210047 A5 DD210047 A5 DD 210047A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- substituted
- trans
- octahydro
- pyrazolo
- solution
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Extraction Or Liquid Replacement (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43883482A | 1982-11-03 | 1982-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DD210047A5 true DD210047A5 (de) | 1984-05-30 |
Family
ID=23742220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DD83253428A DD210047A5 (de) | 1982-11-03 | 1983-07-27 | Verfahren zur herstellung von trans-dl-5-substituierten 7-gegebenenfalls-substituierten-4,4a,5,6,7,8,8a,9-octahydro-1h(und 2h)pyrazolo(3,4-g)chinolinen |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0110496B1 (xx) |
| JP (3) | JPS5982366A (xx) |
| KR (1) | KR870000234B1 (xx) |
| AT (1) | ATE29252T1 (xx) |
| AU (1) | AU551687B2 (xx) |
| CA (1) | CA1259313A (xx) |
| DD (1) | DD210047A5 (xx) |
| DE (1) | DE3373303D1 (xx) |
| DK (1) | DK343283A (xx) |
| ES (1) | ES8501395A1 (xx) |
| FI (1) | FI832719A (xx) |
| GB (1) | GB2130576B (xx) |
| GR (1) | GR77559B (xx) |
| HU (2) | HU194176B (xx) |
| IE (1) | IE55668B1 (xx) |
| IL (1) | IL69358A (xx) |
| NZ (1) | NZ205031A (xx) |
| PL (2) | PL250137A1 (xx) |
| PT (1) | PT77111B (xx) |
| RO (1) | RO86894B (xx) |
| ZA (1) | ZA835501B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EG17490A (en) * | 1984-08-03 | 1992-06-30 | Lilly Co Eli | Improvements in or relating to tricyclic quinoline derivatives |
| US4764609A (en) * | 1986-03-31 | 1988-08-16 | Eli Lilly And Company | Synthesis of 2-aminopyrimido[4,5-g]quinolines |
| US4826986A (en) * | 1986-06-16 | 1989-05-02 | Eli Lilly And Company | 6-Oxo-trans-octa- and decahydroquinolines |
| US7249161B2 (en) * | 2002-12-27 | 2007-07-24 | Nokia Corporation | Method and system for facilitating instant messaging transactions between disparate service providers |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230861A (en) * | 1979-01-22 | 1980-10-28 | Eli Lilly And Company | 1-And/or 7-substituted-6-hydroxy (or oxo)-3-decahydroquinoline carboxylic acids |
-
1983
- 1983-07-26 ES ES524453A patent/ES8501395A1/es not_active Expired
- 1983-07-27 RO RO111743A patent/RO86894B/ro unknown
- 1983-07-27 IL IL69358A patent/IL69358A/xx not_active IP Right Cessation
- 1983-07-27 ZA ZA835501A patent/ZA835501B/xx unknown
- 1983-07-27 JP JP58138681A patent/JPS5982366A/ja active Granted
- 1983-07-27 HU HU86814A patent/HU194176B/hu unknown
- 1983-07-27 GR GR72055A patent/GR77559B/el unknown
- 1983-07-27 IE IE1773/83A patent/IE55668B1/en not_active IP Right Cessation
- 1983-07-27 FI FI832719A patent/FI832719A/fi not_active Application Discontinuation
- 1983-07-27 HU HU832646A patent/HU190728B/hu not_active IP Right Cessation
- 1983-07-27 PL PL25013783A patent/PL250137A1/xx unknown
- 1983-07-27 PL PL24320083A patent/PL243200A1/xx unknown
- 1983-07-27 KR KR1019830003503A patent/KR870000234B1/ko not_active IP Right Cessation
- 1983-07-27 AT AT83304340T patent/ATE29252T1/de not_active IP Right Cessation
- 1983-07-27 DK DK343283A patent/DK343283A/da unknown
- 1983-07-27 DD DD83253428A patent/DD210047A5/de unknown
- 1983-07-27 DE DE8383304340T patent/DE3373303D1/de not_active Expired
- 1983-07-27 PT PT77111A patent/PT77111B/pt unknown
- 1983-07-27 AU AU17339/83A patent/AU551687B2/en not_active Ceased
- 1983-07-27 NZ NZ205031A patent/NZ205031A/en unknown
- 1983-07-27 CA CA000433331A patent/CA1259313A/en not_active Expired
- 1983-07-27 EP EP83304340A patent/EP0110496B1/en not_active Expired
- 1983-07-27 GB GB08320248A patent/GB2130576B/en not_active Expired
-
1991
- 1991-03-27 JP JP3089660A patent/JPH04217979A/ja active Granted
- 1991-03-27 JP JP3089661A patent/JPH0662618B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2001017C3 (de) | 3,4-Dihydro-1,23-oxathiazin-4on-2,2-dioxide, ihre Herstellung und Verwendung | |
| EP0173199A1 (de) | cis, endo-2-Azabicycloalkan-3-carbonsäure-Derivate, Verfahren zu deren Herstellung, deren Verwendung sowie Zwischenprodukte bei deren Herstellung | |
| DE2062001C2 (de) | 1,2,3,4-Tetrahydro-4-phenylisochinolin-Derivate, deren Säureadditionssalze, Verfahren zu deren Herstellung und pharmazeutisches Präparat | |
| DE3023626A1 (de) | 1,9-dihydroxyoctahydrobenzo eckige klammer auf c eckige klammer zu chinoline und 1-hydroxyhexahydrobenzo eckige klammer auf c eckige klammer zu chinolin-9 (8h)- one als antiemetika | |
| DD140040A5 (de) | Verfahren zur herstellung von 5-alkylthio-pyrimidinen | |
| CH629782A5 (de) | Verfahren zur herstellung von 4-hydroxy-aporphinderivaten. | |
| DD210047A5 (de) | Verfahren zur herstellung von trans-dl-5-substituierten 7-gegebenenfalls-substituierten-4,4a,5,6,7,8,8a,9-octahydro-1h(und 2h)pyrazolo(3,4-g)chinolinen | |
| DE3780015T2 (de) | Kondensierte heterocyclische tetrahydroaminochinolinole und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
| DD216022A5 (de) | Verfahren zur herstellung einer neuen heterocyclischen verbindung | |
| DD210456A5 (de) | Verfahren zur herstellung von pyrazolopyridin-verbindungen | |
| DE1695417A1 (de) | Benzomorphanderivate und Verfahren zu deren Herstellung | |
| DE3715447C2 (de) | Verfahren zur Herstellung einer Mischung von O-(beta-Hydroxyethyl)-diosminen | |
| DD243022A5 (de) | Verfahren zur herstellung neuer 3-phenyl-2-propenamin-derivate | |
| DE2640618A1 (de) | Mittel zur foerderung des wachstums oder zur verbesserung der wirksamkeit der futterumwandlung bei tieren | |
| DE1926023A1 (de) | Verfahren zur Herstellung neuer heterocyclischer Verbindungen | |
| DD148779A5 (de) | Verfahren zur herstellung von vindesin | |
| EP0054002B1 (de) | Verfahren zur Herstellung von 3-Pyrazolidinonen und ihre Verwendung in photographischen Entwicklerlösungen | |
| EP0304624A2 (de) | Benzimidazol-2-yl-pyridiniumverbindungen | |
| DE3781015T2 (de) | Verfahren zur herstellung substituierter anthra(1,9-cd)-pyrazol-6(2h)-one. | |
| DE69016224T2 (de) | Verfahren zur Herstellung von Lactamderivaten. | |
| DE3718589A1 (de) | Neue mono- und polyhydroxyacyl-derivate polyoxygenierter labdane, ein verfahren zu deren herstellung und ihre verwendung als medikamente | |
| DE3909012A1 (de) | Verbessertes verfahren zur herstellung von enantiomerenreinen hetrazepinen | |
| DE2934342C2 (xx) | ||
| DE3707530A1 (de) | Neue substituierte dihalogenpyridine und verfahren zu ihrer herstellung sowie ihre weitere umsetzung zu pyridindicarbonsaeurediestern | |
| EP0159640A1 (de) | 4-Methoxy-2,2'-bipyridyl-6-aldoxime, Verfahren und Zwischenprodukte zu ihrer Herstellung und ihre Verwendung als Arzneimittel |